ClinicalMetric / Countries / Germany / breast cancer
← 🇩🇪 Germany Trials
🇩🇪 Germany Country × Condition

breast cancer Clinical Trials in Germany

Active clinical trials for breast cancer with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 Phases: Phase 4 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇩🇪 Germany

Active Trials in Germany (3)

NCT06274515 Phase 4
Recruiting

A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies

Enrollment
320 pts
Country
🇩🇪 Germany
Hoffmann-La Roche
View Trial →
NCT04075305
Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Enrollment
8,000 pts
Country
🇩🇪 Germany
UMC Utrecht
View Trial →
NCT07140172
Recruiting

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery

Enrollment
1,060 pts
Country
🇩🇪 Germany
University Hospital, Basel, Switzer...
View Trial →

Frequently Asked Questions

How many breast cancer clinical trials are active in Germany?
There are currently 3 active clinical trials for breast cancer with sites in Germany, of which 3 are actively recruiting patients.
How can I join a breast cancer clinical trial in Germany?
To join a breast cancer clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer trials in Germany?
Active breast cancer trials in Germany span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Germany Trials → Global breast cancer Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology